<?xml version="1.0" encoding="UTF-8"?>
<p>
 <italic>Artemisiae abrotani herba</italic> and 
 <italic>Artemisiae abrotani folium</italic> do not have the status of pharmacopoeial raw materials in European countries. The species and the raw materials obtained from it are, however, successfully used in official European allopathic medicine. A good example is the research conducted at Havelhoehe Research Institute and Charite’ University Medical Centre in Berlin, and the University of Witten/Herdecke in Herdecke (Germany). For a period of two years (2004–2005), it was recorded the prescribing by primary care doctors and specialist doctors of preparations containing plant extracts from plants of the family Asteraceae. Over that time, preparations with 
 <italic>A. abrotanum</italic> extracts were recommended to 202 patients. The preparations included both homeopathic remedies and herbal mixtures as well as medicines containing only 
 <italic>A. abrotanum</italic> extract. The indications for the use of these medications were usually diagnosed non-infectious inflammations of the intestines or of the large intestine [
 <xref rid="B45-molecules-26-02503" ref-type="bibr">45</xref>,
 <xref rid="B61-molecules-26-02503" ref-type="bibr">61</xref>]. 
</p>
